A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Hormone-sensitive Prostate Cancer
Interventions
- DRUG: Darolutamide (BAY1841788, Nubeqa)
- OTHER: ADT
Sponsor
Bayer